US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 1.760
  • -0.040-2.22%
Close Jul 29 16:00 ET
14.29MMarket Cap-384P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-40.20%-12.89M
-16.80%-31.1M
-26.90%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.20%-26.62M
-0.26%-5.83M
21.67%-5.52M
-13.58%-7.25M
Net income from continuing operations
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-13.86%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
9.53%-7.84M
Depreciation and amortization
-77.78%2K
-10.20%44K
-48.57%18K
100.00%8K
550.00%9K
-25.00%9K
-77.42%49K
34.62%35K
100.00%4K
-110.53%-2K
Other non cash items
99.26%-1K
-1,407.69%-392K
---30K
---91K
---135K
---136K
---26K
----
----
----
Change In working capital
-31.34%-3.03M
-53.96%965K
-14.96%1.55M
-99.65%4K
6,511.54%1.72M
-159.55%-2.31M
190.58%2.1M
364.49%1.83M
2,370.00%1.14M
-98.18%26K
-Change in receivables
31.82%29K
114.13%13K
13.64%-38K
481.25%61K
-28.00%-32K
414.29%22K
-167.65%-92K
-266.67%-44K
-277.78%-16K
-136.23%-25K
-Change in prepaid assets
32.04%-437K
38.01%679K
42.39%833K
-32.20%320K
-61.33%169K
35.83%-643K
145.30%492K
135.89%585K
-29.13%472K
225.21%437K
-Change in payables and accrued expense
-55.48%-2.63M
-83.90%273K
-41.04%757K
-155.52%-377K
509.84%1.58M
-1,519.33%-1.69M
224.34%1.7M
238.66%1.28M
193.66%679K
-122.63%-386K
Cash from discontinued investing activities
Operating cash flow
-40.20%-12.89M
-16.80%-31.1M
-26.90%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.20%-26.62M
-0.26%-5.83M
21.67%-5.52M
-13.58%-7.25M
Investing cash flow
Cash flow from continuing investing activities
140.60%1M
194.58%10.74M
154.34%6.17M
5.95M
1.08M
-2.46M
-143.74%-11.36M
-37,760.00%-11.36M
0
0
Net PPE purchase and sale
----
--0
----
----
----
----
30.00%-21K
----
----
----
Net investment purchase and sale
140.60%1M
194.75%10.74M
154.44%6.17M
--5.95M
--1.08M
---2.46M
---11.34M
---11.34M
--0
--0
Cash from discontinued investing activities
Investing cash flow
140.60%1M
194.58%10.74M
154.34%6.17M
--5.95M
--1.08M
---2.46M
-143.74%-11.36M
-37,760.00%-11.36M
--0
--0
Financing cash flow
Cash flow from continuing financing activities
98.38%-5K
29.84%-576K
256.21%742K
-33.44%-435K
-28,600.00%-574K
-1,616.67%-309K
-327.60%-821K
-475K
-326K
92.31%-2K
Net common stock issuance
--0
13.33%-585K
251.67%725K
-116.24%-426K
---579K
---305K
---675K
---478K
---197K
--0
Proceeds from stock option exercised by employees
----
-60.67%35K
-29.17%17K
--0
----
----
27.14%89K
--24K
--35K
----
Net other financing activities
-25.00%-5K
88.94%-26K
--0
94.51%-9K
59.38%-13K
77.78%-4K
10.31%-235K
---21K
---164K
54.29%-32K
Cash from discontinued financing activities
Financing cash flow
98.38%-5K
29.84%-576K
256.21%742K
-33.44%-435K
-28,600.00%-574K
-1,616.67%-309K
-327.60%-821K
---475K
---326K
92.31%-2K
Net cash flow
Beginning cash position
-37.37%35.08M
-40.93%56.01M
-51.73%35.56M
-52.38%37.86M
-49.24%44.04M
-40.93%56.01M
-3.92%94.81M
-26.81%73.67M
-26.17%79.51M
-23.96%86.76M
Current changes in cash
0.58%-11.9M
46.06%-20.93M
97.29%-479K
60.56%-2.31M
14.78%-6.18M
-48.66%-11.97M
-902.64%-38.8M
-202.33%-17.66M
17.05%-5.85M
-13.15%-7.25M
End cash Position
-47.37%23.18M
-37.37%35.08M
-37.37%35.08M
-51.73%35.56M
-52.38%37.86M
-49.24%44.04M
-40.93%56.01M
-40.93%56.01M
-26.81%73.67M
-26.17%79.51M
Free cash flow
-40.20%-12.89M
-16.71%-31.1M
-26.44%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.22%-26.64M
-0.10%-5.85M
21.67%-5.52M
-13.58%-7.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -40.20%-12.89M-16.80%-31.1M-26.90%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.20%-26.62M-0.26%-5.83M21.67%-5.52M-13.58%-7.25M
Net income from continuing operations -42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-13.86%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M9.53%-7.84M
Depreciation and amortization -77.78%2K-10.20%44K-48.57%18K100.00%8K550.00%9K-25.00%9K-77.42%49K34.62%35K100.00%4K-110.53%-2K
Other non cash items 99.26%-1K-1,407.69%-392K---30K---91K---135K---136K---26K------------
Change In working capital -31.34%-3.03M-53.96%965K-14.96%1.55M-99.65%4K6,511.54%1.72M-159.55%-2.31M190.58%2.1M364.49%1.83M2,370.00%1.14M-98.18%26K
-Change in receivables 31.82%29K114.13%13K13.64%-38K481.25%61K-28.00%-32K414.29%22K-167.65%-92K-266.67%-44K-277.78%-16K-136.23%-25K
-Change in prepaid assets 32.04%-437K38.01%679K42.39%833K-32.20%320K-61.33%169K35.83%-643K145.30%492K135.89%585K-29.13%472K225.21%437K
-Change in payables and accrued expense -55.48%-2.63M-83.90%273K-41.04%757K-155.52%-377K509.84%1.58M-1,519.33%-1.69M224.34%1.7M238.66%1.28M193.66%679K-122.63%-386K
Cash from discontinued investing activities
Operating cash flow -40.20%-12.89M-16.80%-31.1M-26.90%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.20%-26.62M-0.26%-5.83M21.67%-5.52M-13.58%-7.25M
Investing cash flow
Cash flow from continuing investing activities 140.60%1M194.58%10.74M154.34%6.17M5.95M1.08M-2.46M-143.74%-11.36M-37,760.00%-11.36M00
Net PPE purchase and sale ------0----------------30.00%-21K------------
Net investment purchase and sale 140.60%1M194.75%10.74M154.44%6.17M--5.95M--1.08M---2.46M---11.34M---11.34M--0--0
Cash from discontinued investing activities
Investing cash flow 140.60%1M194.58%10.74M154.34%6.17M--5.95M--1.08M---2.46M-143.74%-11.36M-37,760.00%-11.36M--0--0
Financing cash flow
Cash flow from continuing financing activities 98.38%-5K29.84%-576K256.21%742K-33.44%-435K-28,600.00%-574K-1,616.67%-309K-327.60%-821K-475K-326K92.31%-2K
Net common stock issuance --013.33%-585K251.67%725K-116.24%-426K---579K---305K---675K---478K---197K--0
Proceeds from stock option exercised by employees -----60.67%35K-29.17%17K--0--------27.14%89K--24K--35K----
Net other financing activities -25.00%-5K88.94%-26K--094.51%-9K59.38%-13K77.78%-4K10.31%-235K---21K---164K54.29%-32K
Cash from discontinued financing activities
Financing cash flow 98.38%-5K29.84%-576K256.21%742K-33.44%-435K-28,600.00%-574K-1,616.67%-309K-327.60%-821K---475K---326K92.31%-2K
Net cash flow
Beginning cash position -37.37%35.08M-40.93%56.01M-51.73%35.56M-52.38%37.86M-49.24%44.04M-40.93%56.01M-3.92%94.81M-26.81%73.67M-26.17%79.51M-23.96%86.76M
Current changes in cash 0.58%-11.9M46.06%-20.93M97.29%-479K60.56%-2.31M14.78%-6.18M-48.66%-11.97M-902.64%-38.8M-202.33%-17.66M17.05%-5.85M-13.15%-7.25M
End cash Position -47.37%23.18M-37.37%35.08M-37.37%35.08M-51.73%35.56M-52.38%37.86M-49.24%44.04M-40.93%56.01M-40.93%56.01M-26.81%73.67M-26.17%79.51M
Free cash flow -40.20%-12.89M-16.71%-31.1M-26.44%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.22%-26.64M-0.10%-5.85M21.67%-5.52M-13.58%-7.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-9.06%